PRESS RELEASE published on 01/23/2023 at 12:15, 2 years 2 months ago Hardman & Co Q&A on Shield Therapeutics (STX): Positioned for profitability with Viatris deal and its additional capital
PRESS RELEASE published on 01/18/2023 at 15:15, 2 years 2 months ago Hardman & Co Q&A on Oakley Capital Investments Ltd (OCI): High-growth drivers in 2023
PRESS RELEASE published on 01/17/2023 at 16:10, 2 years 2 months ago Hardman & Co Research on Advanced Oncotherapy (AVO): Understanding the significance of 230MeV
PRESS RELEASE published on 01/16/2023 at 08:00, 2 years 2 months ago Hardman & Co Research on Cornerstone FS (CSFS): Strong FY22 update and Avila House divestment
PRESS RELEASE published on 01/13/2023 at 12:10, 2 years 2 months ago Hardman & Co Research on Apax Global Alpha (Initiation of coverage): Making pearls out of oysters
PRESS RELEASE published on 01/13/2023 at 08:15, 2 years 2 months ago Hardman & Co Research: Shield Therapeutics (STX) - Positioned for growth and profitability
PRESS RELEASE published on 01/03/2023 at 17:10, 2 years 2 months ago Hardman & Co Research on The Fulham Shore (FUL): Resilient first-half trading
Published on 03/28/2025 at 18:00, 54 minutes ago D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq:IVP) in Connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Published on 03/28/2025 at 14:15, 4 hours 39 minutes ago Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern
Published on 03/28/2025 at 14:00, 4 hours 54 minutes ago 83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey
Published on 03/28/2025 at 14:00, 4 hours 54 minutes ago UniDoc Completes Purchase of AGNES Connect(R) Software from AMD Telemedicine
Published on 03/28/2025 at 18:30, 24 minutes ago EPIC Suisse AG – Annual General Meeting 2025 approves all proposals by the Board of Directors
Published on 03/28/2025 at 18:29, 25 minutes ago CPI Europe with sound earnings development and robust balance sheet in 2024
Published on 03/28/2025 at 17:52, 1 hour 2 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 03/28/2025 at 17:45, 1 hour 9 minutes ago Sale of domestic Brazilian business successfully completed
Published on 03/28/2025 at 17:45, 1 hour 9 minutes ago Availability of the 2024 Universal Registration Document including the Annual Financial Report
Published on 03/28/2025 at 17:45, 1 hour 9 minutes ago Publication of Carrefour's 2024 Universal Registration Document
Published on 03/28/2025 at 17:45, 1 hour 9 minutes ago Covivio - Conditions of availability of preparatory documents to the Combined Ordinary and Extraordinary General Meeting of 17 April 2025
Published on 03/27/2025 at 18:40, 1 day ago The Combined Ordinary and Extraordinary General Meeting of April 17, 2025
